Brexit policy remains at odds with industry as Johnson becomes PM

With Boris Johnson set to become prime minister on Wednesday, just 100 days before the U.K. is scheduled to leave the EU, his rhetoric on Brexit remains largely at odds with the biopharma industry.

Johnson was elected leader of the Conservative Party on Tuesday. During his campaign, he has stated that he intends to take the U.K. out of the EU on Oct. 31, regardless of whether or not a deal is in place with the EU...